Updating Efficacy of First‐Line Treatments for Chronic Lymphocytic Leukemia: Indirect Comparisons Based on Recent Data Favor the Combination of Acalabrutinib Plus Obinutuzumab

European Journal Of Haematology 2026

View at publisher

Authors: Andrea Messori

DOI: 10.1111/ejh.70150

Cited by: 1

References: 2

Abstract

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Chronic Lymphocytic Leukemia Research HER2/EGFR in Cancer Research Chronic Myeloid Leukemia Treatments

References 2